25.07.2024 12:12:13
|
West Pharmaceutical Services Inc. Q2 Profit Decreases, Misses Estimates
(RTTNews) - West Pharmaceutical Services Inc. (WST) revealed a profit for second quarter that decreased from last year and missed the Street estimates.
The company's earnings came in at $111.3 million, or $1.51 per share. This compares with $155.1 million, or $2.06 per share, in last year's second quarter.
Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $112 million or $1.52 per share for the period.
Analysts on average had expected the company to earn $1.74 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 6.9% to $702.1 million from $753.8 million last year.
West Pharmaceutical Services Inc. earnings at a glance (GAAP) :
-Earnings (Q2): $111.3 Mln. vs. $155.1 Mln. last year. -EPS (Q2): $1.51 vs. $2.06 last year. -Revenue (Q2): $702.1 Mln vs. $753.8 Mln last year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu West Pharmaceutical Services Inc.mehr Nachrichten
14.02.25 |
NYSE-Handel: S&P 500 klettert (finanzen.at) | |
14.02.25 |
S&P 500-Handel aktuell: S&P 500 in der Gewinnzone (finanzen.at) | |
14.02.25 |
Zuversicht in New York: S&P 500 beginnt Sitzung mit Gewinnen (finanzen.at) | |
13.02.25 |
Handel in New York: S&P 500 notiert zum Handelsende im Plus (finanzen.at) | |
13.02.25 |
Donnerstagshandel in New York: Anleger lassen S&P 500 am Donnerstagnachmittag steigen (finanzen.at) | |
13.02.25 |
Gute Stimmung in New York: S&P 500 verbucht am Donnerstagmittag Gewinne (finanzen.at) | |
13.02.25 |
S&P 500 aktuell: S&P 500 zum Handelsstart mit Gewinnen (finanzen.at) | |
12.02.25 |
Ausblick: West Pharmaceutical Services legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu West Pharmaceutical Services Inc.mehr Analysen
Aktien in diesem Artikel
West Pharmaceutical Services Inc. | 202,00 | 0,00% |
|